Eledon Pharmaceuticals, Inc. (ELDN) Net income 2016–2025
Eledon Pharmaceuticals, Inc. (ELDN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$45.6MFY2025 · since FY2016: -$5.7M → -$45.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.6M | -26.1% |
| FY2024 | -$36.2M | +69.0% |
| FY2023 | -$116.5M | -32.5% |
| FY2022 | -$88.0M | -154.9% |
| FY2021 | -$34.5M | -51.3% |
| FY2020 | -$22.8M | -42.5% |
| FY2019 | -$16.0M | -13.8% |
| FY2018 | -$14.1M | -7.2% |
| FY2017 | -$13.1M | -131.9% |
| FY2016 | -$5.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice